Evaluation of antimicrobial agents in animal models of infections involving bacteroides fragilis

Keith A Joiner, J. G. Bartlett

Research output: Contribution to journalArticle

Abstract

Antimicrobial agents were examined for relative efficacy against Bacteroides fragilis in two animal models. In one model, rats were challenged with cecal contents intraperitoneally to produce intra-abdominal abscesses containing a mixed aerobic-anaerobic flora. Efficacy of antimicrobials was measured by assessing decrease in mortality and decrease in the incidence of abscess formation. Metronidazole, clindamycin, carbenicillin, moxalactam, cefoxitin, moxalactam, cefoxitin and cefotaxime gave the best results in lowering the rate of abscess formation; these drugs were more effective than cephalothin, cefazolin or cefamandole. The second model involved challenge of mice subcutaneously with a pure culture of B. fragilis to produce a mono-infected, well-encapsulated abscess. Quantitative counts of bacteria were used to assess in-vivo antimicrobial activity. Metronidazole, clindamycin, moxalactam, and cefoxitin were found to be the most effective agents, reducing mean bacterial counts by 106.7, 105.0, 103.8, and 103.5, respectively. Thienamycin, cefotaxime, carbenicillin, and ceftizoxime had a significant but less marked effect, while cefoperazone, cephalothin, ceforanide, and ampicillin were relatively inactive against B. fragilis. A delay in treatment of 8 to 120 hours after challenge showed a noticeable reduction in activity, except with metronidazole. It is presumed that bacteria within an abscess are in a stationary growth phase, and this has an important influence on in=vivo efficacy.

Original languageEnglish (US)
Pages (from-to)96-102
Number of pages7
JournalSoutheast Asian Journal of Surgery
Volume8
Issue number1 SUPPL.
StatePublished - 1985
Externally publishedYes

Fingerprint

Bacteroides fragilis
Moxalactam
Anti-Infective Agents
Cefoxitin
Abscess
Metronidazole
Animal Models
Carbenicillin
Cephalothin
Cefotaxime
Clindamycin
Infection
Ceftizoxime
Cefamandole
Abdominal Abscess
Bacteria
Cefoperazone
Cefazolin
Bacterial Load
Reducing Agents

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Evaluation of antimicrobial agents in animal models of infections involving bacteroides fragilis. / Joiner, Keith A; Bartlett, J. G.

In: Southeast Asian Journal of Surgery, Vol. 8, No. 1 SUPPL., 1985, p. 96-102.

Research output: Contribution to journalArticle

@article{f04fb9dc35ea44e5ac3f167b68347d6f,
title = "Evaluation of antimicrobial agents in animal models of infections involving bacteroides fragilis",
abstract = "Antimicrobial agents were examined for relative efficacy against Bacteroides fragilis in two animal models. In one model, rats were challenged with cecal contents intraperitoneally to produce intra-abdominal abscesses containing a mixed aerobic-anaerobic flora. Efficacy of antimicrobials was measured by assessing decrease in mortality and decrease in the incidence of abscess formation. Metronidazole, clindamycin, carbenicillin, moxalactam, cefoxitin, moxalactam, cefoxitin and cefotaxime gave the best results in lowering the rate of abscess formation; these drugs were more effective than cephalothin, cefazolin or cefamandole. The second model involved challenge of mice subcutaneously with a pure culture of B. fragilis to produce a mono-infected, well-encapsulated abscess. Quantitative counts of bacteria were used to assess in-vivo antimicrobial activity. Metronidazole, clindamycin, moxalactam, and cefoxitin were found to be the most effective agents, reducing mean bacterial counts by 106.7, 105.0, 103.8, and 103.5, respectively. Thienamycin, cefotaxime, carbenicillin, and ceftizoxime had a significant but less marked effect, while cefoperazone, cephalothin, ceforanide, and ampicillin were relatively inactive against B. fragilis. A delay in treatment of 8 to 120 hours after challenge showed a noticeable reduction in activity, except with metronidazole. It is presumed that bacteria within an abscess are in a stationary growth phase, and this has an important influence on in=vivo efficacy.",
author = "Joiner, {Keith A} and Bartlett, {J. G.}",
year = "1985",
language = "English (US)",
volume = "8",
pages = "96--102",
journal = "Asian Journal of Surgery",
issn = "1015-9584",
publisher = "Elsevier Taiwan LLC",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Evaluation of antimicrobial agents in animal models of infections involving bacteroides fragilis

AU - Joiner, Keith A

AU - Bartlett, J. G.

PY - 1985

Y1 - 1985

N2 - Antimicrobial agents were examined for relative efficacy against Bacteroides fragilis in two animal models. In one model, rats were challenged with cecal contents intraperitoneally to produce intra-abdominal abscesses containing a mixed aerobic-anaerobic flora. Efficacy of antimicrobials was measured by assessing decrease in mortality and decrease in the incidence of abscess formation. Metronidazole, clindamycin, carbenicillin, moxalactam, cefoxitin, moxalactam, cefoxitin and cefotaxime gave the best results in lowering the rate of abscess formation; these drugs were more effective than cephalothin, cefazolin or cefamandole. The second model involved challenge of mice subcutaneously with a pure culture of B. fragilis to produce a mono-infected, well-encapsulated abscess. Quantitative counts of bacteria were used to assess in-vivo antimicrobial activity. Metronidazole, clindamycin, moxalactam, and cefoxitin were found to be the most effective agents, reducing mean bacterial counts by 106.7, 105.0, 103.8, and 103.5, respectively. Thienamycin, cefotaxime, carbenicillin, and ceftizoxime had a significant but less marked effect, while cefoperazone, cephalothin, ceforanide, and ampicillin were relatively inactive against B. fragilis. A delay in treatment of 8 to 120 hours after challenge showed a noticeable reduction in activity, except with metronidazole. It is presumed that bacteria within an abscess are in a stationary growth phase, and this has an important influence on in=vivo efficacy.

AB - Antimicrobial agents were examined for relative efficacy against Bacteroides fragilis in two animal models. In one model, rats were challenged with cecal contents intraperitoneally to produce intra-abdominal abscesses containing a mixed aerobic-anaerobic flora. Efficacy of antimicrobials was measured by assessing decrease in mortality and decrease in the incidence of abscess formation. Metronidazole, clindamycin, carbenicillin, moxalactam, cefoxitin, moxalactam, cefoxitin and cefotaxime gave the best results in lowering the rate of abscess formation; these drugs were more effective than cephalothin, cefazolin or cefamandole. The second model involved challenge of mice subcutaneously with a pure culture of B. fragilis to produce a mono-infected, well-encapsulated abscess. Quantitative counts of bacteria were used to assess in-vivo antimicrobial activity. Metronidazole, clindamycin, moxalactam, and cefoxitin were found to be the most effective agents, reducing mean bacterial counts by 106.7, 105.0, 103.8, and 103.5, respectively. Thienamycin, cefotaxime, carbenicillin, and ceftizoxime had a significant but less marked effect, while cefoperazone, cephalothin, ceforanide, and ampicillin were relatively inactive against B. fragilis. A delay in treatment of 8 to 120 hours after challenge showed a noticeable reduction in activity, except with metronidazole. It is presumed that bacteria within an abscess are in a stationary growth phase, and this has an important influence on in=vivo efficacy.

UR - http://www.scopus.com/inward/record.url?scp=0021946049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021946049&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 96

EP - 102

JO - Asian Journal of Surgery

JF - Asian Journal of Surgery

SN - 1015-9584

IS - 1 SUPPL.

ER -